Overview
Haifeng Li practices practicing medicine in Wuxi, China.
Their clinical expertise encompasses Necrosis, Guillain-Barre Syndrome, Osteonecrosis, and Osteoporosis.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haifeng Li
Is Haifeng Li a top-rated expert for Necrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Haifeng Li is classified as an Experienced expert for Necrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haifeng Li participate in research or clinical trials?
Yes. Haifeng Li has published 25 articles and abstracts on conditions like Necrosis. You can view a list of Haifeng Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorLi isExperienced. Learn about Bone Tumor.
- Guillain-Barre SyndromeLi isExperienced. Learn about Guillain-Barre Syndrome.
- NecrosisLi isExperienced. Learn about Necrosis.
- OsteonecrosisLi isExperienced. Learn about Osteonecrosis.
- OsteoporosisLi isExperienced. Learn about Osteoporosis.
- OsteosarcomaLi isExperienced. Learn about Osteosarcoma.